Christian Angermayer - Jun 2, 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Director, 10%+ Owner
Signature
/s/ Ryan Barrett, Attorney-in-fact
Stock symbol
ATAI
Transactions as of
Jun 2, 2025
Transactions value $
$0
Form type
4
Date filed
6/4/2025, 04:38 PM
Previous filing
Oct 4, 2024
Next filing
Jun 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Angermayer Christian Director, 10%+ Owner 66 & 67, BEATRICE, AMERY STREET, SLIEMA, MALTA /s/ Ryan Barrett, Attorney-in-fact 2025-06-04 0001845872

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award +132K 132K Jun 2, 2025 Common Shares 132K $2.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 2, 2025, the Issuer granted stock options to the Reporting Person in further consideration of his continued service as a consultant and other valuable consideration.
F2 The stock options shall vest as to 25% on June 2, 2026, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person entering into an amended consultancy agreement, the Reporting Person's continued service to the Issuer through each applicable vesting date and Apeiron Investment Group Ltd.'s compliance with the Voting Agreement dated as of June 2, 2025 by and among Beckley Psytech Limited, Atai Life Sciences N.V. and Apeiron Investment Group Ltd.